| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 疼痛管理类产品(元) | 95,065,989.54 | 248,425,846.56 | 106,917,591.45 | 220,976,748.22 | 95,068,799.87 |
| 医疗器械CXO(元) | - | - | - | - | 2,184,335.51 |
| 鼻腔护理类产品(元) | 46,800,199.60 | 123,381,551.94 | 56,410,097.04 | 183,098,947.67 | 82,060,028.24 |
| 其他产品(元) | 17,300,499.44 | 30,496,803.68 | 16,137,552.25 | 16,710,148.85 | 9,383,928.90 |
| 营业成本(元) | |||||
| 疼痛管理类产品(元) | 30,766,806.46 | 73,488,654.56 | 30,748,025.61 | 90,497,434.30 | 41,404,551.01 |
| 医疗器械CXO(元) | - | - | - | - | 1,493,006.73 |
| 鼻腔护理类产品(元) | 12,207,845.69 | 27,102,340.91 | 13,243,148.56 | 38,649,486.96 | 19,244,149.89 |
| 其他产品(元) | 15,563,431.94 | 26,128,632.94 | 13,091,719.32 | 15,624,455.19 | 9,565,378.27 |
| 毛利(元) | |||||
| 疼痛管理类产品(元) | 64,299,183.08 | 174,937,192.00 | 76,169,565.84 | 130,479,313.92 | 53,664,248.86 |
| 医疗器械CXO(元) | - | - | - | - | 691,328.78 |
| 鼻腔护理类产品(元) | 34,592,353.91 | 96,279,211.03 | 43,166,948.48 | 144,449,460.71 | 62,815,878.35 |
| 其他产品(元) | 1,737,067.50 | 4,368,170.74 | 3,045,832.93 | 1,085,693.66 | -181,449.37 |
| 毛利率(%) | |||||
| 疼痛管理类产品(%) | 67.64 | 70.42 | 71.24 | 59.05 | 56.45 |
| 医疗器械CXO(%) | - | - | - | - | 31.65 |
| 鼻腔护理类产品(%) | 73.91 | 78.03 | 76.52 | 78.89 | 76.55 |
| 其他产品(%) | 10.04 | 14.32 | 18.87 | 6.50 | -1.93 |
| 收入构成(%) | |||||
| 疼痛管理类产品(%) | 59.73 | 61.75 | 59.58 | 52.52 | 50.38 |
| 医疗器械CXO(%) | - | - | - | - | 1.16 |
| 鼻腔护理类产品(%) | 29.40 | 30.67 | 31.43 | 43.51 | 43.49 |
| 其他产品(%) | 10.87 | 7.58 | 8.99 | 3.97 | 4.97 |
| 毛利构成(%) | |||||
| 疼痛管理类产品(%) | 63.90 | 63.48 | 62.24 | 47.27 | 45.87 |
| 医疗器械CXO(%) | - | - | - | - | 0.59 |
| 鼻腔护理类产品(%) | 34.38 | 34.94 | 35.27 | 52.33 | 53.69 |
| 其他产品(%) | 1.73 | 1.59 | 2.49 | 0.39 | -0.16 |